Search

Scott Callahan is the second Gerstner Sloan Kettering student to receive the Joanna M. Nicolay Melanoma Foundation grant, which supports exceptional melanoma research by graduate students.

… Monday, April 28, 2014 Scott Callahan, a second-year student studying in the laboratories of Lorenz Studer in the Developmental Biology Program and Richard M. White in the Cancer Biology and Genetics Program , was awarded a $10,000 melanoma research grant by the Joanna M. Nicolay Melanoma Foundation

Learn why some patients are less physically active during and after treatment — plus, some tips from Jun Mao, Chief of the Integrative Medicine Service at MSK.

… Wednesday, January 25, 2017 Summary In a recent survey, 75% of people with cancer said they reduced their physical activity after their diagnosis. We spoke with two experts from the Integrative Medicine Service at MSK to learn more. A new study led by Memorial Sloan Kettering researchers shows that 75%

Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during The American Society of Hematology (ASH) annual meeting, December 9-12 in San Diego, CA.

… Tuesday, December 5, 2023 Physicians and scientists from Memorial Sloan Kettering Cancer Center (MSK) will join oncology experts and members of the global cancer research community to present the latest advances in cancer during The American Society of Hematology (ASH) annual meeting, December 9-12 in

For those living with advanced cancer, quality of life means pursuing what matters most to each person — whether that’s making art, running marathons, caring for others, or spending more time with family.

… Friday, June 6, 2025 Cancer that spreads from an initial tumor to other parts of the body — known as metastasis — is a daunting diagnosis that brings with it a great deal of fear and uncertainty. While metastatic cancer remains challenging, significant advances in diagnosis and treatment are making it

Overcoming resistance to drug treatment for lung cancer is a critical challenge.

… Thursday, November 29, 2018 Summary Investigators are looking for ways to overcome resistance to drugs that target lung cancer. Lung cancer was one of the first cancers that could be targeted by drugs aimed at specific mutations in tumors. Advances in genomic medicine and the molecular analysis of tumors

Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years.

… Wednesday, September 27, 2006 Results from the largest study of men with prostate cancer treated with high-dose, intensity modulated radiation therapy (IMRT) show that the majority of patients remain alive with no evidence of disease after an average follow-up period of eight years. The 561 prostate

Memorial Sloan Kettering attained Magnet recognition for the second time, a testament to our continued dedication to high-quality nursing practice.

… Wednesday, November 25, 2020 VIDEO | 03:09 2020 MSK Nurses Magnet Recognition Video Details On November 23, 2020, Memorial Sloan Kettering (MSK) attained Magnet recognition for the second time, a testament to our continued dedication to high-quality nursing practice. The American Nurses Credentialing

MSK’s Convocation and the Gerstner Sloan Kettering Graduate School of Biomedical Sciences Commencement celebrate the achievements of young scientists.

… Wednesday, June 10, 2015 Ruth Anne Franklin (left), Ming Li, Myoungjoo Kim Graduates Ruth Anne Franklin (left) and Myoungjoo Kim with their mentor, immunologist Ming Li 2015 graduates Graduates of GSK and a joint program between Weill Cornell Medical College and the Sloan Kettering Institute with their

New MSK research provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates acquired resistance to immunotherapy in non-small cell lung cancer.

… Monday, January 29, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) provides insights into how BRCA2 promotes genomic integrity; illuminates how embryonic cells can develop without key amino acids; explores how the microbiome bounces back after antibiotic treatment; and investigates

Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story.

… Thursday, July 3, 2014 Summary Olympic gymnast Shannon Miller was diagnosed with germ cell ovarian cancer, a very rare disease, in 2011 and treated at Memorial Sloan Kettering. Learn more about her inspiring story. “Celebrating survivorship is an important reminder of why MSK exists.” —Memorial Sloan